Join experts Dr. Ana Franceschi and Dr. Jonathon McConathy as they dive into the cutting-edge role of PET imaging in Alzheimer’s disease from a US perspective. In this practical discussion, you will gain valuable insights into the strengths and limitations of amyloid and tau PET biomarkers in the context of the US healthcare system. The discussion also highlights best practices for selecting, interpreting, and reporting PET findings, offering nuanced and practical guidance to integrate these approaches into everyday clinical workflows.
Select your language for captions by clicking on 
icon.
Subtitles are available in English, French, Spanish, Italian and German, Japanese and Simplified Chinese.
If you have any questions or comments on the topics discussed, please share these through our Imaging Exchange.
Title: Expert Exchange: The US Perspective
Release date: June 19, 2025
Expiration date: June 19, 2026
Estimated time to complete activity: 45 minutes
This program is intended for Imaging physicians, including Nuclear Medicine Physicians, Radiologists, Neuroradiologists, Radiology Physician Assistants, Imaging Residents. It is also suitable for Neurologists.
Following completion of this independent educational program, you will be able to:
Dr Ana M Franceschi
Associate Professor of Radiology,
Lennox Hill Hospital, NY, USA
Disclosures
Honoraria/Consultation fees from Biogen, Eisai, Eli Lilly, Roche, Siemens Healthineers, MIM Software, Cardinal Health, Life Molecular Imaging, Blue Earth Diagnostics, Icometrix, Cortechs, PeerView.
Prof Jonathan E. McConathy
Professor and Director, Division of Molecular Imaging and Therapeutics,University of Alabama, Birmingham, USA
Disclosures
Honoraria from Novartis, Telix, Eli Lilly/Avid; Consulting fees from GE Healthcare, Novartis; and research support from Eli Lilly/Avid, GE Healthcare.
Other financial or material support
Clinical trial sponsors: Cytosite Biopharma, RayzeBio, Novartis, Telix, Fusion Pharmaceuticals, Clarity Pharmaceuticals
Credits available
Completing one Expert Exchange activity will earn you 0.5 AMA PRA Category 1 Credit(s)™. You can earn a total of 1.5 credits for all three activities.
In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine and Springer Healthcare IME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As part of the planning committee Rebecca Cox and Jules Morgan have no interests to disclose. The PIM staff has no financial relationships to disclose. All relevant financial relationships have been mitigated.
